Eur Rev Med Pharmacol Sci 2025; 29 (8): 381-381
DOI: 10.26355/eurrev_202508_37364

Author Correction: Serum irisin levels in colorectal cancer patients

Z. Celik, N.K. Baygutalp, A.F. Kilic, S.B. Tekin, E. Bakan, M.A. Gul, N. Yuce

Department of Biomaterials and Tissue Engineering, Institute of Science, Harran University, Şanlıurfa, Turkey


Correction to: Eur Rev Med Pharmacol Sci 2023; 27 (4): 1474-1479–DOI: 10.26355/eurrev_202302_31387–PMID: 36876687 published online on 1 March 2023. 

This erratum serves to include the ethics approval date and approval number, which were unintentionally omitted from the originally published online version of the article. 

Therefore, the Ethics Approval statement has been corrected as follows: 

Institutional ethics approval was obtained from the Clinical Research Ethics Committee of the Faculty of Medicine, Ataturk University on May 30, 2019, with approval number 241, and informed consent was provided by all the participants. 

There are amendments to this paper. The Publisher apologizes for any inconvenience this may cause. 

Serum irisin levels in colorectal cancer patients

Free PDF Download

To cite this article

Z. Celik, N.K. Baygutalp, A.F. Kilic, S.B. Tekin, E. Bakan, M.A. Gul, N. Yuce
Author Correction: Serum irisin levels in colorectal cancer patients

Eur Rev Med Pharmacol Sci
Year: 2025
Vol. 29 - N. 8
Pages: 381-381
DOI: 10.26355/eurrev_202508_37364

Publication History

Published online: 29 Aug 2025